| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 811 | 115 | +606.2% |
| EBITDA | 101 | −4.5 | — |
| EBITDA margin | 12.5% | −4.0% | +16.4 pts |
| Profit before tax | 47.1 | −49.2 | — |
| Net profit | 35.0 | −37.9 | — |
| EPS | ₹4.04 | −₹5.37 | — |
| Tap a line for its trend | Q2 FY27Sep 2026 | Q1 FY27Jun 2026 | Q4 FY26Mar 2026 | Q3 FY26Dec 2025 | Q2 FY26Sep 2025 | Q1 FY26Jun 2025 |
|---|
| 811 | 627 | 596 | 713 | 115 | 304 | |
| 12.6 | 14.5 | 31.4 | 17.6 | 14.8 | 22.7 | |
| 824 | 641 | 627 | 731 | 130 | 327 | |
Expenses | ||||||
| 229 | 334 | 471 | 423 | 89.3 | 73.5 | |
| 275 | 10.6 | 53.7 | 120 | 3.6 | 22.5 | |
| 112 | 47.7 | −216 | −49.4 | −0.7 | 124 | |
| 12.1 | 12.1 | 13.5 | 12.5 | 10.7 | 11.2 | |
| 42.5 | 44.0 | 43.5 | 40.1 | 38.6 | 37.8 | |
| 24.2 | 24.8 | 22.9 | 21.8 | 20.8 | 20.7 | |
| 81.6 | 90.3 | 155 | 73.0 | 16.5 | 31.4 | |
| 777 | 563 | 543 | 641 | 179 | 321 | |
| 101 | 133 | 119 | 134 | −4.5 | 41.5 | |
| 76.9 | 108 | 95.8 | 112 | −25.3 | 20.8 | |
Profit | ||||||
| 47.1 | 78.4 | 83.7 | 89.7 | −49.2 | 5.8 | |
| 47.1 | 78.4 | 83.7 | 89.7 | −49.2 | 5.8 | |
| 0.6 | 0.9 | 0.5 | 0.7 | 1.3 | 0.0 | |
| 11.5 | 18.3 | 22.2 | 19.8 | −12.5 | 1.1 | |
| 12.1 | 19.2 | 22.8 | 20.5 | −11.2 | 1.1 | |
| 35.0 | 59.3 | 60.9 | 69.2 | −37.9 | 4.7 | |
| 35.0 | 59.3 | 60.9 | 69.2 | −37.9 | 4.7 | |
| −0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |
| 34.9 | 59.3 | 61.0 | 69.2 | −37.9 | 4.7 | |
| 34.7 | 57.2 | 59.9 | 69.3 | −37.9 | 4.7 | |
| 0.3 | 2.1 | 1.1 | −0.1 | 0.0 | 0.0 | |
Per share | ||||||
| ₹4.04 | ₹6.67 | ₹6.99 | ₹8.07 | −₹5.37 | ₹0.67 | |
| ₹4.04 | ₹6.67 | ₹6.99 | ₹8.07 | −₹5.37 | ₹0.67 | |
Other comprehensive income — detail | ||||||
| −0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | |
| −0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | |
| −0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 34.7 | 57.2 | 60.0 | 69.4 | −37.9 | 4.7 | |
| 0.3 | 2.1 | 1.1 | −0.1 | 0.0 | 0.0 | |
Per share — as-filed variants | ||||||
| ₹4.04 | ₹6.67 | ₹6.99 | ₹8.07 | −₹5.37 | ₹0.67 | |
| ₹4.04 | ₹6.67 | ₹6.99 | ₹8.07 | −₹5.37 | ₹0.67 | |
Derived — gross profit (revenue − materials − purchases − Δ inventories) | ||||||
| 195 | 235 | 287 | 219 | 22.6 | 84.1 | |
| 24.0% | 37.5% | 48.2% | 30.8% | 19.7% | 27.7% | |
Adjusted (ex-exceptional items) — derived | ||||||
| 47.1 | 78.4 | 83.7 | 89.7 | −49.2 | 5.8 | |
| 35.0 | 59.3 | 60.9 | 69.2 | −37.9 | 4.7 | |
| ₹4.04 | ₹6.67 | ₹6.99 | ₹8.07 | −₹5.37 | ₹0.67 | |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 3 Months Ending | Q1 FY26 30/06/2025 | Q2 FY26 30/09/2025 | Q3 FY26 31/12/2025 | Q4 FY26 31/03/2026 | Q1 FY27 30/06/2026 | Q2 FY27 30/09/2026 | |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 303.9 | 114.9 | 713.2 | 595.5 | 626.9 | 811.1 | |
| Other Income | 22.7 | 14.8 | 17.6 | 31.4 | 14.5 | 12.6 | |
| Total Income | 326.6 | 129.6 | 730.9 | 626.9 | 641.4 | 823.7 | |
| Expenses | |||||||
| + Cost of Materials Consumed | 73.5 | 89.3 | 423.3 | 471.3 | 333.5 | 228.6 | |
| + Purchases of Stock-in-Trade | 22.5 | 3.6 | 119.9 | 53.7 | 10.6 | 275.3 | |
| + Changes in Inventories | 123.7 | -0.7 | -49.4 | -216.3 | 47.7 | 112.4 | |
| + Employee Benefit Expense | 11.2 | 10.7 | 12.5 | 13.5 | 12.1 | 12.1 | |
| + Finance Costs | 37.8 | 38.6 | 40.1 | 43.5 | 44.0 | 42.5 | |
| + Depreciation & Amortisation | 20.7 | 20.8 | 21.8 | 22.9 | 24.8 | 24.2 | |
| + Other Expenses | 31.4 | 16.5 | 73.0 | 154.5 | 90.3 | 81.6 | |
| Total Expenses | 320.8 | 178.8 | 641.2 | 543.2 | 563.0 | 776.6 | |
| EBITDA | 41.5 | -4.5 | 134.0 | 118.8 | 132.8 | 101.2 | |
| EBIT | 20.8 | -25.3 | 112.2 | 95.8 | 108.0 | 76.9 | |
| Profit | |||||||
| PBT before Exceptional Items | 5.8 | -49.2 | 89.7 | 83.7 | 78.4 | 47.1 | |
| Pretax Income | 5.8 | -49.2 | 89.7 | 83.7 | 78.4 | 47.1 | |
| + Current Tax | 0.0 | 1.3 | 0.7 | 0.5 | 0.9 | 0.6 | |
| + Deferred Tax | 1.1 | -12.5 | 19.8 | 22.2 | 18.3 | 11.5 | |
| Tax Expense | 1.1 | -11.2 | 20.5 | 22.8 | 19.2 | 12.1 | |
| Net Income | 4.7 | -37.9 | 69.2 | 60.9 | 59.3 | 35.0 | |
| + Net Income — Continuing Ops | 4.7 | -37.9 | 69.2 | 60.9 | 59.3 | 35.0 | |
| + Other Comprehensive Income | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | -0.1 | |
| Total Comprehensive Income | 4.7 | -37.9 | 69.2 | 61.0 | 59.3 | 34.9 | |
| Net Income to Common | 4.7 | -37.9 | 69.3 | 59.9 | 57.2 | 34.7 | |
| Minority Interest | 0.0 | 0.0 | -0.1 | 1.1 | 2.1 | 0.3 | |
| Per Share | |||||||
| Basic EPS | 0.67 | -5.37 | 8.07 | 6.99 | 6.67 | 4.04 | |
| Diluted EPS | 0.67 | -5.37 | 8.07 | 6.99 | 6.67 | 4.04 | |
| Other Comprehensive Income — detail | |||||||
| + Other Comprehensive Income | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | -0.1 | |
| + Items NOT to be Reclassified to P&L | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | -0.1 | |
| + Tax on Items NOT to be Reclassified | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.0 | |
| Comprehensive Income — Owners of Parent | 4.7 | -37.9 | 69.4 | 60.0 | 57.2 | 34.7 | |
| Comprehensive Income — Non-controlling Interests | 0.0 | 0.0 | -0.1 | 1.1 | 2.1 | 0.3 | |
| Per Share — as-filed variants | |||||||
| Basic EPS — Continuing Operations | 0.67 | -5.37 | 8.07 | 6.99 | 6.67 | 4.04 | |
| Diluted EPS — Continuing Operations | 0.67 | -5.37 | 8.07 | 6.99 | 6.67 | 4.04 | |
| Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories) | |||||||
| Gross Profit | 84.1 | 22.6 | 219.5 | 286.8 | 235.1 | 194.8 | |
| Gross Margin % | 27.69 | 19.72 | 30.77 | 48.16 | 37.50 | 24.02 | |
| Adjusted (ex-Exceptional Items) — derived | |||||||
| Pretax Income (Adjusted, as filed) | 5.8 | -49.2 | 89.7 | 83.7 | 78.4 | 47.1 | |
| Net Income Adj (tax-effected) | 4.7 | -37.9 | 69.2 | 60.9 | 59.3 | 35.0 | |
| EPS Adj | 0.67 | -5.37 | 8.07 | 6.99 | 6.67 | 4.04 | |
| Other Filed Concepts — mapped but not yet placed in the schedule | |||||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| Filed Debt Equity | 1.38 | — | 0.72 | — | — | — | |
| Filed Dscr | 0.91 | — | 1.05 | — | — | — | |
| Filed Iscr | 1.94 | — | 2.20 | — | — | — | |
| Paid Up Equity Capital | 70.6 | 85.8 | 85.8 | 85.8 | 85.8 | 85.8 | |
Filed with NSE on Friday, 23 October 2026 at 7:48 pm IST
TruAlt Bioenergy (NSE: TRUALT) reported its Q2 FY27 results (July–September 2026) on Friday, 23 October 2026 at 7:48 pm IST. Consolidated net profit was ₹34.7 crore, against a loss of ₹37.9 crore in Q2 FY26 and down 39.3% from ₹57.2 crore in Q1 FY27. Revenue from operations was ₹811 crore, up 606.2% year on year and up 29.4% from the previous quarter.
Consolidated net profit was ₹34.7 crore, against a loss of ₹37.9 crore in Q2 FY26 and down 39.3% from ₹57.2 crore in Q1 FY27.
Revenue from operations was ₹811 crore, up 606.2% year on year and up 29.4% from the previous quarter.
TruAlt Bioenergy's net profit margin was 4.3% in Q2 FY27 (net profit as a share of revenue from operations), against −33.0% in Q2 FY26 (up 37.2 percentage points). For FY26 as a whole it was 5.6%.
A net profit of ₹34.7 crore, against a loss of ₹37.9 crore in Q2 FY26. Revenue was up 606.2% at ₹811 crore. The operating margin was 9.5%, up 31.5 percentage points from −22.1% a year earlier. Against Q1 FY27, net profit was down 39.3% and revenue up 29.4%.
Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹76.9 crore, a margin of 9.5%, against 17.2% in Q1 FY27 and −22.1% in Q2 FY26. EBITDA was ₹101 crore, 12.5% of revenue.
Consolidated net profit for the first half of FY27 (April–September 2026) was ₹91.8 crore, against a loss of ₹33.1 crore in the same months a year earlier. Revenue from operations was ₹1,438 crore, up 243.4%.
Basic earnings per share were ₹4.04.
Consolidated net profit was ₹95.9 crore in FY26 (April 2025–March 2026).
Revenue from operations was ₹1,728 crore in FY26 (April 2025–March 2026).
Net profit by quarter: ₹69.3 crore in Q3 FY26, ₹59.9 crore in Q4 FY26, ₹57.2 crore in Q1 FY27 and ₹34.7 crore in Q2 FY27. That is ₹221 crore over the four quarters. Revenue from operations: ₹713 crore, ₹596 crore, ₹627 crore and ₹811 crore.
On Friday, 23 October 2026 at 7:48 pm IST, in its results filing to the stock exchanges. A year earlier it reported Q2 FY26 on 11 November 2025.
Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.
From TruAlt Bioenergy's own consolidated results filings to NSE, in ₹ crore as filed (Q2 FY27 on 23 October 2026). Growth compares the same consolidated figures a year and a quarter earlier.
Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.